Macrophages surrounding lymph nodes block the progression of melanoma, other cancers
- Details
- Category: Research
Researchers at Massachusetts General Hospital (MGH) have identified a type of immune cell that appears to block the progress of melanoma and other cancers in animal models. These subcapsular sinus (SCS) macrophages form a protective coating around lymph nodes, preventing the entry of tiny structures that transport bits of tumor tissue and help the cancer to grow and spread.
Nanoparticles show promise for treating intestinal inflammation
- Details
- Category: Research
Nanoparticles designed to block a cell-surface molecule that plays a key role in inflammation could be a safe treatment for inflammatory bowel disease (IBD), according to researchers in the Institute for Biomedical Sciences at Georgia State University and Southwest University in China.
Results of world's first study on new treatment for heroin addiction
- Details
- Category: Research
The results of the ground-breaking SALOME research, published in the Journal of the American Medical Association (JAMA) Psychiatry, show chronic heroin addiction now has another effective treatment tool - hyrdomorphone, a licensed pain medication. SALOME, which stands for the Study to Assess Longer-term Opioid Medication Effectiveness, found hydromorphone (HDM) to be as effective as diacetylmorphine
Vitamin D improves heart function, study finds
- Details
- Category: Research
A daily dose of vitamin D3 improves heart function in people with chronic heart failure, a five-year University of Leeds research project has found. Dr Klaus Witte, from the School of Medicine and Consultant Cardiologist at Leeds Teaching Hospitals NHS Trust, led the study, known as VINDICATE.
New insights in blood vessel formation
- Details
- Category: Research
How vascular tubes build, maintain and adapt continuously perfused lumens to meet local metabolic needs remains poorly understood. Recent studies showed that blood flow itself plays a critical role in the remodelling of vascular networks and suggested it is also required for the lumenization of new vascular connections.
New insights in cancer therapy from cell death research
- Details
- Category: Research
Researchers in the group of Prof. Dr. Peter Vandenabeele (VIB/UGent) show that killed tumour cells can serve as a potent vaccine that stimulates the immune system to prevent the outgrowth of cancer cells. This finding opens novel perspectives for the use of necroptosis as a part of immunotherapy and for the screening for novel or existing cancer drugs that induce this type of immunogenic cell death.
New hope for a type 2 diabetes cure
- Details
- Category: Research
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes. The team - made up of scientists from the Scripps Research Institute in United States, South Korea-based company Hyndai Pharm Co., Ltd., the Seoul National University, and Ulsan National Institute of Science and Technology (UNIST)
More Pharma News ...
- Scientists resurrect an abandoned drug, find it effective against human viruses
- Encouraging foundation for upcoming AIDS vaccine clinical trial
- Increased vitamin C in the diet could help protect against cataracts
- Nanoparticle-based cancer therapies shown to work in humans
- Getting closer to using beer hops to fight disease
- Common painkillers are more dangerous than we think
- 3-D technology enriches human nerve cells for transplant to brain